Study of the Concentration-effect Relationship of Nivolumab in Patients With Kidney or Lung Cancer
Phase of Trial: Phase IV
Latest Information Update: 04 Apr 2018
At a glance
- Drugs Nivolumab (Primary)
- Indications Non-small cell lung cancer; Renal cell carcinoma; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms NIVEAL
- 02 Mar 2018 Planned End Date changed from 1 Feb 2020 to 1 Jan 2020.
- 02 Mar 2018 Planned primary completion date changed from 1 Feb 2020 to 1 Jan 2020.
- 02 Mar 2018 Status changed from not yet recruiting to recruiting.